Fingerprint
Dive into the research topics of 'Nivolumab Monotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Nivolumab Monotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer
Scott Gettinger, Naiyer A. Rizvi, Laura Q. Chow, Hossein Borghaei, Julie Brahmer, Neal Ready, David E. Gerber, Frances A. Shepherd, Scott Antonia, Jonathan W. Goldman, Rosalyn A. Juergens, Scott A. Laurie, Faith E. Nathan, Yun Shen, Christopher T. Harbison, Matthew D. Hellmann
Research output: Contribution to journal › Article › peer-review
432
Scopus
citations